Molecular evidence for mitochondrial dysfunction in bipolar disorder
- PMID: 14993118
- DOI: 10.1001/archpsyc.61.3.300
Molecular evidence for mitochondrial dysfunction in bipolar disorder
Erratum in
- Arch Gen Psychiatry. 2004 Jun;61(6):538
Abstract
Background: The disease mechanism of bipolar disorder remains unknown. Recent studies have provided evidence for abnormal gene expression in bipolar disorder.
Objective: To determine the expression of 12558 nuclear genes in the human hippocampus in healthy control subjects and those with bipolar disorder or schizophrenia.
Design: We used gene arrays to study messenger RNA expression. Data were verified with a real-time quantitative polymerase chain reaction assay.
Subjects: We studied 10 healthy control subjects, 9 subjects with bipolar disorder, and 8 subjects with schizophrenia.
Results: The expression of nuclear messenger RNA coding for mitochondrial proteins was significantly decreased in the hippocampus in subjects with bipolar disorder but not in those with schizophrenia. Subjects with bipolar disorder were characterized by a pronounced and extensive decrease in the expression of genes regulating oxidative phosphorylation and the adenosine triphosphate-dependent process of proteasome degradation.
Conclusions: These findings point toward a widespread dysregulation of mitochondrial energy metabolism and downstream deficits of adenosine triphosphate-dependent processes in bipolar disorder.
Similar articles
-
Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia.Biol Psychiatry. 2005 Mar 1;57(5):525-32. doi: 10.1016/j.biopsych.2004.11.041. Biol Psychiatry. 2005. PMID: 15737668
-
Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study.Biol Psychiatry. 2004 Apr 1;55(7):676-84. doi: 10.1016/j.biopsych.2003.12.012. Biol Psychiatry. 2004. PMID: 15038995
-
Gene and expression analyses reveal enhanced expression of pericentrin 2 (PCNT2) in bipolar disorder.Biol Psychiatry. 2008 Apr 1;63(7):678-85. doi: 10.1016/j.biopsych.2007.07.010. Epub 2007 Sep 20. Biol Psychiatry. 2008. PMID: 17884020
-
Gene expression profiling in schizophrenia and related mental disorders.Neuroscientist. 2006 Aug;12(4):349-61. doi: 10.1177/1073858406287536. Neuroscientist. 2006. PMID: 16840711 Review.
-
Schizophrenia and bipolar disorder: similarities in pathogenic mechanisms but differences in neurodevelopment.Int Clin Psychopharmacol. 2002 Aug;17 Suppl 3:S11-9. Int Clin Psychopharmacol. 2002. PMID: 12570067 Review.
Cited by
-
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics.Mol Psychiatry. 2015 Jun;20(6):661-70. doi: 10.1038/mp.2015.4. Epub 2015 Feb 17. Mol Psychiatry. 2015. PMID: 25687772 Free PMC article. Review.
-
Differential activation of immune/inflammatory response-related co-expression modules in the hippocampus across the major psychiatric disorders.Mol Psychiatry. 2016 Mar;21(3):376-85. doi: 10.1038/mp.2015.79. Epub 2015 Jun 16. Mol Psychiatry. 2016. PMID: 26077692
-
Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder.J Psychiatry Neurosci. 2006 May;31(3):189-96. J Psychiatry Neurosci. 2006. PMID: 16699605 Free PMC article.
-
Validating mitochondrial electron transport chain content in individuals at clinical high risk for psychosis.Sci Rep. 2019 Sep 3;9(1):12695. doi: 10.1038/s41598-019-49180-3. Sci Rep. 2019. PMID: 31481687 Free PMC article.
-
Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.J Psychiatry Neurosci. 2006 Sep;31(5):326-32. J Psychiatry Neurosci. 2006. PMID: 16951735 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical